{
  "trial_id": "NCT03283176",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HCV-related liver cirrhosis",
      "label": "met",
      "evidence": "previous positive HCV RNA tests"
    },
    {
      "criterion": "candidate for therapy with Sofosbuvir and Daclatasvir with or without Ribavirin",
      "label": "met",
      "evidence": "direct antiviral drugs were added to his treatment 6 months ago"
    }
  ],
  "exclusion": [
    {
      "criterion": "Chronic hepatitis due causes other than chronic HCV infection",
      "label": "not_met",
      "evidence": "no evidence of alcoholic liver disease, bleeding from esophageal varices, hemochromatosis, autoimmune hepatitis or metabolic liver disease"
    },
    {
      "criterion": "Coinfection with HIV or HBV infection",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Hepatocellular carcinoma",
      "label": "not_met",
      "evidence": "recent biopsy was negative for hepatocellular carcinoma"
    },
    {
      "criterion": "Decompensated cirrhosis",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has chronic HCV infection and is on combination therapy with IFN, RBV, and direct antiviral drugs. His medical record shows previous positive HCV RNA tests.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT03283176",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}